154 related articles for article (PubMed ID: 36161584)
1. Circulating heat shock protein 90 (Hsp90) in atopic dermatitis and bullous pemphigoid: is there a link?
Tukaj S
Cell Stress Chaperones; 2022 Nov; 27(6):601-602. PubMed ID: 36161584
[No Abstract] [Full Text] [Related]
2. Aberrant expression and secretion of heat shock protein 90 in patients with bullous pemphigoid.
Tukaj S; Kleszczyński K; Vafia K; Groth S; Meyersburg D; Trzonkowski P; Ludwig RJ; Zillikens D; Schmidt E; Fischer TW; Kasperkiewicz M
PLoS One; 2013; 8(7):e70496. PubMed ID: 23936217
[TBL] [Abstract][Full Text] [Related]
3. Hsp90 blockade modulates bullous pemphigoid IgG-induced IL-8 production by keratinocytes.
Tukaj S; Grüner D; Zillikens D; Kasperkiewicz M
Cell Stress Chaperones; 2014 Nov; 19(6):887-94. PubMed ID: 24796797
[TBL] [Abstract][Full Text] [Related]
4. Circulating heat shock protein 90 (Hsp90) and autoantibodies to Hsp90 are increased in patients with atopic dermatitis.
Sitko K; Bednarek M; Mantej J; Trzeciak M; Tukaj S
Cell Stress Chaperones; 2021 Nov; 26(6):1001-1007. PubMed ID: 34532820
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a role of autoantibodies to heat shock protein 60, 70, and 90 in patients with dermatitis herpetiformis.
Kasperkiewicz M; Tukaj S; Gembicki AJ; Silló P; Görög A; Zillikens D; Kárpáti S
Cell Stress Chaperones; 2014 Nov; 19(6):837-43. PubMed ID: 24643797
[TBL] [Abstract][Full Text] [Related]
6. Heat shock protein 90: a pathophysiological factor and novel treatment target in autoimmune bullous skin diseases.
Tukaj S; Zillikens D; Kasperkiewicz M
Exp Dermatol; 2015 Aug; 24(8):567-71. PubMed ID: 25980533
[TBL] [Abstract][Full Text] [Related]
7. Childhood vesicular pemphigoid mimicking severe atopic dermatitis: a case report.
Belhadjali H; Youssef M; Njim L; Chaabane S; Sriha B; Chakroun M; Zakhama A; Zili J
Cutis; 2009 Apr; 83(4):182-4. PubMed ID: 19445308
[TBL] [Abstract][Full Text] [Related]
8. Heat shock protein 90 inhibition: A potential double- or triple-edged sword in the treatment of mucous membrane pemphigoid.
Kasperkiewicz M; Płatkowska A; Zalewska A; Zillikens D
Med Hypotheses; 2015 Oct; 85(4):412-4. PubMed ID: 26152650
[TBL] [Abstract][Full Text] [Related]
9. Childhood bullous pemphigoid treated by i.v. immunoglobulin.
Xiao T; Li B; Wang YK; He CD; Chen HD
J Dermatol; 2007 Sep; 34(9):650-3. PubMed ID: 17727369
[TBL] [Abstract][Full Text] [Related]
10. Increased serum CCL28 levels in patients with atopic dermatitis, psoriasis vulgaris and bullous pemphigoid.
Kagami S; Kakinuma T; Saeki H; Tsunemi Y; Fujita H; Sasaki K; Nakamura K; Takekoshi T; Kishimoto M; Mitsui H; Komine M; Asahina A; Tamaki K
J Invest Dermatol; 2005 May; 124(5):1088-90. PubMed ID: 15854059
[No Abstract] [Full Text] [Related]
11. A highly sensitive and simple assay for the detection of circulating autoantibodies against full-length bullous pemphigoid antigen 180.
Schmidt E; Kromminga A; Mimietz S; Leinfelder U; Sitaru C; Bröcker EB; Zillikens D; Zimmermann U
J Autoimmun; 2002 Jun; 18(4):299-309. PubMed ID: 12144811
[TBL] [Abstract][Full Text] [Related]
12. Correlation between nuclear expression of heat shock protein 90 in dermis and glucocorticoid resistance in bullous dermatosis.
Huang H; Wang W; Cui Y; Hu CX; Du M
Steroids; 2023 Jun; 194():109223. PubMed ID: 36948346
[TBL] [Abstract][Full Text] [Related]
13. Development of an ELISA to detect anti-BP180 autoantibodies in bullous pemphigoid and herpes gestationis.
Giudice GJ; Wilske KC; Anhalt GJ; Fairley JA; Taylor AF; Emery DJ; Hoffman RG; Diaz LA
J Invest Dermatol; 1994 Jun; 102(6):878-81. PubMed ID: 7516396
[TBL] [Abstract][Full Text] [Related]
14. Circulating bullous pemphigoid autoantibodies in the setting of negative direct immunofluorescence findings for bullous pemphigoid: A single-center retrospective review.
Wang M; Lehman JS; Camilleri MJ; Drage LA; Wieland CN
J Am Acad Dermatol; 2019 Aug; 81(2):472-479. PubMed ID: 30928465
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin G subclass distribution of bullous pemphigoid autoantibodies and complement fixation studies.
Al-Karawi KS
Saudi Med J; 2002 Dec; 23(12):1492-5. PubMed ID: 12518199
[TBL] [Abstract][Full Text] [Related]
16. A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid.
Zillikens D; Mascaro JM; Rose PA; Liu Z; Ewing SM; Caux F; Hoffmann RG; Diaz LA; Giudice GJ
J Invest Dermatol; 1997 Nov; 109(5):679-83. PubMed ID: 9347799
[TBL] [Abstract][Full Text] [Related]
17. Heat shock protein 90 (Hsp90) inhibitor STA-9090 (Ganetespib) ameliorates inflammation in a mouse model of atopic dermatitis.
Sitko K; Starke M; Tukaj S
Cell Stress Chaperones; 2023 Nov; 28(6):935-942. PubMed ID: 37851180
[TBL] [Abstract][Full Text] [Related]
18. Expression of selected ADAMs in bullous pemphigoid and dermatitis herpetiformis.
Zebrowska A; Wagrowska-Danilewicz M; Danilewicz M; Wodz K; Sokolowska M; Erkiert-Polguj A; Sysa-Jedrzejowska A; Waszczykowska E; Pawliczak R
J Dermatol Sci; 2009 Oct; 56(1):58-61. PubMed ID: 19695840
[No Abstract] [Full Text] [Related]
19. Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid.
Verraes S; Hornebeck W; Polette M; Borradori L; Bernard P
J Invest Dermatol; 2001 Nov; 117(5):1091-6. PubMed ID: 11710917
[TBL] [Abstract][Full Text] [Related]
20. [Bullous pemphigoid in young patients: a retrospective study of 74 cases].
Bourdon-Lanoy E; Roujeau JC; Joly P; Guillaume JC; Bernard P; Prost C; Tancrède-Bohin E; Delaporte E; Picard-Dahan C; Albes B; Bedane C; Doutre MS; Chosidow O; Lok C; Pauwels C; Chevrand-Breton J; Sassolas B; Richard MA
Ann Dermatol Venereol; 2005 Feb; 132(2):115-22. PubMed ID: 15798559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
